These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 38375482)

  • 1. Intramuscular vaccination against SARS-CoV-2 transiently induces neutralizing IgG rather than IgA in the saliva.
    Winklmeier S; Rübsamen H; Özdemir C; Wratil PR; Lupoli G; Stern M; Schneider C; Eisenhut K; Ho S; Wong HK; Taskin D; Petry M; Weigand M; Eichhorn P; Foesel BU; Mader S; Keppler OT; Kümpfel T; Meinl E
    Front Immunol; 2024; 15():1330864. PubMed ID: 38375482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccination and Omicron BA.1/BA.2 Convalescence Enhance Systemic but Not Mucosal Immunity against BA.4/5.
    Diem G; Jäger M; Dichtl S; Bauer A; Lass-Flörl C; Reindl M; Wilflingseder D; Posch W
    Microbiol Spectr; 2023 Jun; 11(3):e0516322. PubMed ID: 37098903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum and Salivary IgG and IgA Response After COVID-19 Messenger RNA Vaccination.
    Gorochov G; Ropers J; Launay O; Dorgham K; da Mata-Jardin O; Lebbah S; Durier C; Bauer R; Radenne A; Desaint C; Vieillard LV; Rekacewicz C; Lachatre M; Parfait B; Batteux F; Hupé P; Ninove L; Lefebvre M; Conrad A; Dussol B; Maakaroun-Vermesse Z; Melica G; Nicolas JF; Verdon R; Kiladjian JJ; Loubet P; Schmidt-Mutter C; Dualé C; Ansart S; Botelho-Nevers E; Lelièvre JD; de Lamballerie X; Kieny MP; Tartour E; Paul S
    JAMA Netw Open; 2024 Apr; 7(4):e248051. PubMed ID: 38652471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. mRNA vaccination drives differential mucosal neutralizing antibody profiles in naïve and SARS-CoV-2 previously-infected individuals.
    Longet S; Hargreaves A; Healy S; Brown R; Hornsby HR; Meardon N; Tipton T; Barnes E; Dunachie S; Duncan CJA; Klenerman P; Richter A; Turtle L; de Silva TI; Carroll MW
    Front Immunol; 2022; 13():953949. PubMed ID: 36159846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucosal immune response after the booster dose of the BNT162b2 COVID-19 vaccine.
    Azzi L; Dalla Gasperina D; Veronesi G; Shallak M; Maurino V; Baj A; Gianfagna F; Cavallo P; Dentali F; Tettamanti L; Maggi F; Maffioli LS; Tagliabue A; Accolla RS; Forlani G
    EBioMedicine; 2023 Feb; 88():104435. PubMed ID: 36628844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intramuscular mRNA BNT162b2 vaccine against SARS-CoV-2 induces neutralizing salivary IgA.
    Stolovich-Rain M; Kumari S; Friedman A; Kirillov S; Socol Y; Billan M; Pal RR; Das K; Golding P; Oiknine-Djian E; Sirhan S; Sagie MB; Cohen-Kfir E; Gold N; Fahoum J; Kumar M; Elgrably-Weiss M; Zhou B; Ravins M; Gatt YE; Bhattacharya S; Zelig O; Wiener R; Wolf DG; Elinav H; Strahilevitz J; Padawer D; Baraz L; Rouvinski A
    Front Immunol; 2022; 13():933347. PubMed ID: 36798518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the systemic and mucosal immune response induced by COVID-19 and the BNT162b2 mRNA vaccine for SARS-CoV-2.
    Nickel O; Rockstroh A; Wolf J; Landgraf S; Kalbitz S; Kellner N; Borte M; Pietsch C; Fertey J; Lübbert C; Ulbert S; Borte S
    PLoS One; 2022; 17(10):e0263861. PubMed ID: 36256664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2-Neutralizing Humoral IgA Response Occurs Earlier but Is Modest and Diminishes Faster than IgG Response.
    Takamatsu Y; Omata K; Shimizu Y; Kinoshita-Iwamoto N; Terada M; Suzuki T; Morioka S; Uemura Y; Ohmagari N; Maeda K; Mitsuya H
    Microbiol Spectr; 2022 Dec; 10(6):e0271622. PubMed ID: 36219096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BNT162b2 vaccine induces antibody release in saliva: a possible role for mucosal viral protection?
    Darwich A; Pozzi C; Fornasa G; Lizier M; Azzolini E; Spadoni I; Carli F; Voza A; Desai A; Ferrero C; Germagnoli L; ; Mantovani A; Rescigno M
    EMBO Mol Med; 2022 May; 14(5):e15326. PubMed ID: 35393790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucosal immune response in BNT162b2 COVID-19 vaccine recipients.
    Azzi L; Dalla Gasperina D; Veronesi G; Shallak M; Ietto G; Iovino D; Baj A; Gianfagna F; Maurino V; Focosi D; Maggi F; Ferrario MM; Dentali F; Carcano G; Tagliabue A; Maffioli LS; Accolla RS; Forlani G
    EBioMedicine; 2022 Jan; 75():103788. PubMed ID: 34954658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are SARS-CoV-2 Antibodies Detectable in Human Milk After Vaccination Against COVID-19?
    Scaggs Huang F
    J Pediatric Infect Dis Soc; 2022 Apr; 11(4):126. PubMed ID: 35394545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2-Specific Immune Responses in Vaccination and Infection during the Pandemic in 2020-2022.
    Inoue W; Kimura Y; Okamoto S; Nogimori T; Sakaguchi-Mikami A; Yamamoto T; Tsunetsugu-Yokota Y
    Viruses; 2024 Mar; 16(3):. PubMed ID: 38543812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-SARS-CoV-2 IgA and IgG in human milk after vaccination is dependent on vaccine type and previous SARS-CoV-2 exposure: a longitudinal study.
    Selma-Royo M; Bäuerl C; Mena-Tudela D; Aguilar-Camprubí L; Pérez-Cano FJ; Parra-Llorca A; Lerin C; Martínez-Costa C; Collado MC
    Genome Med; 2022 Apr; 14(1):42. PubMed ID: 35449030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of anti-SARS-CoV-2 salivary antibodies in vaccinated adults.
    Castro VT; Chardin H; Amorim Dos Santos J; Barra GB; Castilho GR; Souza PM; Magalhães PO; Acevedo AC; Guerra ENS
    Front Immunol; 2023; 14():1296603. PubMed ID: 38022522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of Serum and Mucosal SARS-CoV-2-Antibodies in HIV-1-Infected Subjects after BNT162b2 mRNA Vaccination or SARS-CoV-2 Infection.
    Schmidt KG; Harrer EG; Tascilar K; Kübel S; El Kenz B; Hartmann F; Simon D; Schett G; Nganou-Makamdop K; Harrer T
    Viruses; 2022 Mar; 14(3):. PubMed ID: 35337058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody Responses to BNT162b2 Vaccination in Japan: Monitoring Vaccine Efficacy by Measuring IgG Antibodies against the Receptor-Binding Domain of SARS-CoV-2.
    Fujigaki H; Yamamoto Y; Koseki T; Banno S; Ando T; Ito H; Fujita T; Naruse H; Hata T; Moriyama S; Takahashi Y; Suzuki T; Murakami T; Yoshida Y; Yagura Y; Oyamada T; Takemura M; Kondo M; Iwata M; Saito K
    Microbiol Spectr; 2022 Feb; 10(1):e0118121. PubMed ID: 35044205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucosal antibody responses following Vaxzevria vaccination.
    Selva KJ; Ramanathan P; Haycroft ER; Tan CW; Wang LF; Downie LE; Davis SK; Purcell RA; Kent HE; Juno JA; Wheatley AK; Davenport MP; Kent SJ; Chung AW
    Immunol Cell Biol; 2023; 101(10):975-983. PubMed ID: 37670482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Human Milk Antibody Induction, Persistence, and Neutralizing Capacity With SARS-CoV-2 Infection vs mRNA Vaccination.
    Young BE; Seppo AE; Diaz N; Rosen-Carole C; Nowak-Wegrzyn A; Cruz Vasquez JM; Ferri-Huerta R; Nguyen-Contant P; Fitzgerald T; Sangster MY; Topham DJ; Järvinen KM
    JAMA Pediatr; 2022 Feb; 176(2):159-168. PubMed ID: 34757387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-SARS-CoV-2 Immunoglobulin Isotypes, and Neutralization Activity Against Viral Variants, According to BNT162b2-Vaccination and Infection History.
    Tarkowski M; de Jager W; Schiuma M; Covizzi A; Lai A; Gabrieli A; Corbellino M; Bergna A; Ventura CD; Galli M; Riva A; Antinori S
    Front Immunol; 2021; 12():793191. PubMed ID: 34975897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of anti-SARS-CoV-2 IgG and IgA antibody responses post complete vaccination, 7 months later and after 3rd dose of the BNT162b2 vaccine in healthy adults.
    Rastawicki W; Juszczyk G; Gierczyński R; Zasada AA
    J Clin Virol; 2022 Jul; 152():105193. PubMed ID: 35660747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.